[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction (CHARM)

What is the purpose of the study? (in Layman's terms, please describe the study)

To determine if BIIB093 improves functional outcome when compared with placebo in participants with Large Hemispheric Infarction (LHI)

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:

Phase 3

Patient Age Group:


Principal Investigator:

Julius Gene S Latorre

What is involved if I participate?

  • How long is the study?
    12 months
  • Is transportation provided or reimbursed?
  • Is parking provided or reimbursed?
  • What tests and procedures are involved?
    ECG, neuroimaging, blood tests, NIHSS, mRS

Where will the study take place?

Upstate Hospital

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Lena F Deb
Phone: 315-464-9756
Email: debl@upstate.edu

Return to Previous Page || Search Again